Northern Ireland

UTV political editor Ken Reid is new patron of blood cancer charity Leukaemia & Lymphoma NI

Ken Reid is the new patron of a blood cancer charity
Ken Reid is the new patron of a blood cancer charity Ken Reid is the new patron of a blood cancer charity

UTV political editor Ken Reid is the new patron of a blood cancer charity.

A familiar face on television screens providing analysis from Stormont and Westminster, Mr Reid has joined forces with Leukaemia & Lymphoma NI after he himself battled cancer.

The veteran journalist was diagnosed in 2017 with leukaemia but after treatment returned to his job the following year

His appointment as patron of Leukaemia & Lymphoma NI was confirmed today on World Blood Cancer Day.

An average of three people are diagnosed each day with Northern Ireland's third biggest cancer killer - blood cancer.

Mr Reid said: "Research is the key to the future, as the recent attempts to deal with Covid-19 has proved. My leukaemia was discovered a few years ago after some blood tests for my diabetes.

"I am undertaking a clinical trial called Flair which is run from the world class Leeds University Cancer Centre and is supervised by the brilliant team at the Bridgewater Suite at the City Hospital in Belfast.

"I have received so much support from my family, colleagues and ITV which helps me deal with the side effects of fatigue and nausea.

"The current lockdown is difficult. I like many others are shielding and the uncertainty can be worrying. Thankfully ITV have made arrangements that mean I am still able to work from home.

"The research supported by Leukaemia and Lymphoma NI helps patients like me to know that whilst there is currently no cure it is possible to treat and enjoy a decent life."

Joanne Badger from Leukaemia & Lymphoma NI said: "Ken is one of 100 people every month who are diagnosed with some form of blood cancer in Northern Ireland.

"Today is World Blood Cancer Day and our charity is on a mission to raise awareness about the impact of blood cancer and the need to fund life-changing research."